Medicon Hellas S.A. (ATH:MEDIC)
Greece · Delayed Price · Currency is EUR 3.110
0.00 (0.00%)
At close: Oct 27, 2026
Medicon Hellas Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 18.63 | 17.95 | 18.12 | 18.12 | 20.77 | 21.51 |
Revenue Growth | 3.75% | -0.94% | 0.03% | -12.77% | -3.41% | 40.87% |
Gross Profit Gross Profit Growth | 13.64 | 13.11 | 12.88 | 13.02 | 15.48 | 15.69 |
Operating Income Operating Income Growth | 3.04 | 2.21 | 1.65 | 1.78 | 3.85 | 4.99 |
Net Income Net Income Growth | 2.46 | 1.73 | 1.37 | 1.32 | 2.53 | 3.04 |
Earnings Per Share EPS Growth | 0.56 | 0.39 | 0.31 | 0.30 | 0.57 | 0.69 |
EPS Growth | 42.20% | 26.81% | 3.38% | -47.83% | -16.68% | 301.85% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Diagnostic Laboratories Diagnostic Laboratories Growth | 2.45 |
Cosmetics Cosmetics Growth | 0.29 |
Medical Machinery Reaction Agents Medical Machinery Reaction Agents Growth | 15.44 |
Other Intercompany Sales Other Intercompany Sales Growth | -0.23 |
Total Total Growth | 17.95 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 11.66 | 10.68 | 8.51 | 8.46 | 10.21 | 10.36 |
Total Debt Total Debt Growth | 8.81 | 9.24 | 9.44 | 10.65 | 11.03 | 12.11 |
Net Cash (Debt) Net Cash Growth | 2.85 | 1.44 | -0.93 | -2.19 | -0.82 | -1.75 |
Net Cash Growth | 98.40% | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.64 | 0.32 | -0.21 | -0.50 | -0.18 | -0.40 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5.73 | 4.41 | 2 | 0.88 | 1.25 | 4.79 |
Capital Expenditures CapEx Growth | -1.94 | -1.5 | -1.01 | -1.59 | -0.41 | -0.55 |
Free Cash Flow Free Cash Flow Growth | 3.79 | 2.91 | 1 | -0.72 | 0.84 | 4.24 |
Free Cash Flow Growth | 30.28% | 192.35% | - | - | -80.15% | 80.99% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.24% | 73.04% | 71.07% | 71.86% | 74.52% | 72.94% |
Operating Margin | 16.33% | 12.30% | 9.10% | 9.84% | 18.52% | 23.18% |
Pretax Margin | 15.16% | 11.54% | 7.81% | 8.27% | 17.60% | 22.22% |
Profit Margin | 13.23% | 9.65% | 7.54% | 7.29% | 12.20% | 14.14% |
FCF Margin | 20.35% | 16.21% | 5.49% | -3.95% | 4.05% | 19.70% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.130 | - | 0.130 | 0.060 | 0.153 |
Dividend Per Share Growth | 15.38% | - | 116.67% | -60.82% | - |
Dividend Yield | 4.18% | - | 6.02% | 1.80% | 4.14% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 5.58 | 6.45 | 6.99 | 11.14 | 6.46 | 7.09 |
P/FCF Ratio | 3.63 | 3.84 | 9.59 | - | 19.45 | 5.09 |
PS Ratio | 0.74 | 0.62 | 0.53 | 0.81 | 0.79 | 1.00 |